A promising future treatment for lupus
By GREGORY ZELLER // There’s a long tunnel ahead, but for millions around the world suffering from lupus, the light at the end shines brightly. That’s the fervent belief of Meggan Mackay, a board-certified rheumatologist and assistant professor at the Hofstra Northwell School of Medicine. Mackay is initiating a Phase 2 clinical trial of a drug she says might rival today’s best treatments for the autoimmune disease but without the devastating side effects. There’s no…